1. A role for bone turnover markers β-CrossLaps (CTX) and amino-terminal propeptide of type I collagen (PINP) as potential indicators for disease progression from MGUS to multiple myeloma. Issue 10 (3rd October 2018) Authors: Vallet, Sonia; Hoyle, Nicholas R.; Kyle, Robert A.; Podar, Klaus; Pecherstorfer, Martin Journal: Leukemia & lymphoma Issue: Volume 59:Issue 10(2018) Page Start: 2431 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Adoptive cell therapy in multiple Myeloma. (2nd December 2017) Authors: Vallet, Sonia; Pecherstorfer, Martin; Podar, Klaus Journal: Expert opinion on biological therapy Issue: Volume 17:Number 12(2017:Dec.) Page Start: 1511 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Bone marrow microenvironment- induced regulation of Bcl-2 family members in multiple myeloma (MM): Therapeutic implications. (January 2023) Authors: Aksoy, Osman; Lind, Judith; Sunder-Plaßmann, Vincent; Vallet, Sonia; Podar, Klaus Journal: Cytokine Issue: Volume 161(2023) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Choosing an appropriate salvage therapy for a patient with multiple myeloma. (22nd September 2018) Authors: Podar, Klaus Journal: Expert opinion on pharmacotherapy Issue: Volume 19:Number 14(2018) Page Start: 1511 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Current and developing synthetic pharmacotherapy for treating relapsed/refractory multiple myeloma. (24th July 2017) Authors: Podar, Klaus; Pecherstorfer, Martin Journal: Expert opinion on pharmacotherapy Issue: Volume 18:Number 11(2017) Page Start: 1061 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Emerging protein kinase inhibitors for the treatment of multiple myeloma. (3rd July 2019) Authors: Lind, Judith; Czernilofsky, Felix; Vallet, Sonia; Podar, Klaus Journal: Expert opinion on emerging drugs Issue: Volume 24:Number 3(2019) Page Start: 133 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Mcl-1 confers protection of Her2-positive breast cancer cells to hypoxia: therapeutic implications. Issue 1 (December 2016) Authors: Bashari, Muhammad; Fan, Fengjuan; Vallet, Sonia; Sattler, Martin; Arn, Melissa; Luckner-Minden, Claudia; Schulze-Bergkamen, Henning; Zörnig, Inka; Marme, Frederik; Schneeweiss, Andreas; Cardone, Michael; Opferman, Joseph; Jäger, Dirk; Podar, Klaus Journal: Breast cancer research Issue: Volume 18:Issue 1(2016) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. New insights, recent advances, and current challenges in the biological treatment of multiple myeloma. (June 2013) Authors: Vallet, Sonia; Podar, Klaus Journal: Expert opinion on biological therapy Issue: Volume 13(2013)Supplement 1 Page Start: S35 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. On the continuous (R)evolution of antibody-based and CAR T cell therapies in multiple myeloma: an early 2022 glance into the future. (13th August 2022) Authors: Sunder-Plassmann, Vincent; Aksoy, Osman; Lind, Judith; Pecherstorfer, Martin; Vallet, Sonia; Podar, Klaus Journal: Expert opinion on pharmacotherapy Issue: Volume 23:Number 12(2022) Page Start: 1425 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Selinexor for the treatment of multiple myeloma. (3rd March 2020) Authors: Podar, Klaus; Shah, Jatin; Chari, Ajai; Richardson, Paul G; Jagannath, Sundar Journal: Expert opinion on pharmacotherapy Issue: Volume 21:Number 4(2020) Page Start: 399 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗